Special note: As editor-in-chief of the Wisconsin Medical Journal (WMJ), Fahad Aziz, MD, associate professor, Nephrology, is one of the authors of an editorial, Shaping Tomorrow by Advancing Maternal and Child Health, in a special double issue of the journal focused on maternal and child health.

1. Altaras C, Ly MT, Schultz O, Barr WB, Banks SJ, Wethe JV, Tripodis Y, Adler CH, Balcer LJ, Bernick C, Zetterberg H, Blennow K, Ashton N, Peskind E, Cantu RC, Coleman MJ, Lin AP, Koerte IK, Bouix S, Daneshvar D, Dodick DW, Geda YE, Katz DL, Weller JL, Mez J, Palmisano JN, Martin B, Cummings JL, Reiman EM, Shenton ME, Stern RA, Alosco ML. Dispersion-based cognitive intra-individual variability in former American football players: Association with traumatic encephalopathy syndrome, repetitive head impacts, and biomarkers. Clin Neuropsychol. 2025:1-29.
2. An SS, Cao G, Ahn K, Lee J, Jung DY, Denlinger L, Fahy J, Israel E, Moore W, Phillips B, Mauger D, Wenzel S, Panettieri RA, Jr. Serum cAMP levels are increased in patients with asthma. J Clin Invest. 2025.
3. Ao J, Picard C, Auld D, Zetterberg H, Brinkmalm A, Blennow K, Villeneuve S, Breitner JCS, Poirier J. Novel synaptic markers predict early tau pathology and cognitive deficit in an asymptomatic population at risk of Alzheimer's disease. Mol Psychiatry. 2025.
4. Ashton NJ, Zetterberg H. A blood test for Alzheimer's disease: a decade of progress and success. EBioMedicine. 2025;112:105545.
5. Benussi A, Huber H, Tan K, Cantoni V, Rivolta J, Cotelli MS, Benedet AL, Blennow K, Zetterberg H, Ashton NJ, Borroni B. Plasma p-tau(217) and neurofilament/p-tau(217) ratio in differentiating Alzheimer's disease from syndromes associated with frontotemporal lobar degeneration. Alzheimers Dement. 2025.
6. Birkenbihl C, Cuppels M, Boyle RT, Klinger HM, Langford O, Coughlan GT, Properzi MJ, Chhatwal J, Price JC, Schultz AP, Rentz DM, Amariglio RE, Johnson KA, Gottesman RF, Mukherjee S, Maruff P, Lim YY, Masters CL, Beiser A, Resnick SM, Hughes TM, Burnham S, Tunali I, Landau S, Cohen AD, Johnson SC, Betthauser TJ, Seshadri S, Lockhart SN, O'Bryant SE, Vemuri P, Sperling RA, Hohman TJ, Donohue MC, Buckley RF. Rethinking the residual approach: leveraging statistical learning to operationalize cognitive resilience in Alzheimer's disease. Brain Inform. 2025;12(1):3.
7. Blanc KL, Dazzi F, English K, Farge D, Galipeau J, Horwitz EM, Kadri N, Krampera M, Lalu MM, Nolta J, Patel NM, Shi Y, Weiss DJ, Viswanathan S. ISCT MSC committee statement on the US FDA approval of allogenic bone-marrow mesenchymal stromal cells. Cytotherapy. 2025.
8. Brittin NJ, Aceti DJ, Braun DR, Anderson JM, Ericksen SS, Rajski SR, Currie CR, Andes DR, Bugni TS. Dereplication of Natural Product Antifungals via Liquid Chromatography-Tandem Mass Spectrometry and Chemical Genomics. Molecules. 2024;30(1).
9. Caldera F, Kane S, Long M, Hashash JG. Non-colorectal Cancer Screening and Vaccinations in Patients with Inflammatory Bowel Disease: Expert Review. Clin Gastroenterol Hepatol. 2025.
10. Chokkara S, Hermsen MG, Bonomo M, Kaskovich S, Hemmrich MJ, Carey KA, Venable LR, Rojas JC, Churpek MM, Press VG. Comparison of Chart Review and Administrative Data in Developing Predictive Models for Readmissions in Chronic Obstructive Pulmonary Disease. Chronic Obstr Pulm Dis. 2025.
11. Chong JR, Hilal S, Tan BY, Venketasubramanian N, Schöll M, Zetterberg H, Blennow K, Ashton NJ, Chen CP, Lai MKP. Clinical utility of plasma p-tau217 in identifying abnormal brain amyloid burden in an Asian cohort with high prevalence of concomitant cerebrovascular disease. Alzheimers Dement. 2025:e14502.
12. Cicognola C, Salvadó G, Smith R, Palmqvist S, Stomrud E, Betthauser T, Johnson S, Janelidze S, Mattsson-Carlgren N, Hansson O, Pichet Binette A. APOE4 impact on soluble and insoluble tau pathology is mostly influenced by amyloid-beta. Brain. 2025.
13. Clemmensen FK, Gramkow MH, Simonsen AH, Ashton NJ, Huber H, Blennow K, Zetterberg H, Waldemar G, Hasselbalch SG, Frederiksen KS. Short-term variability of Alzheimer's disease plasma biomarkers in a mixed memory clinic cohort. Alzheimers Res Ther. 2025;17(1):26.
14. Descourouez JL, Kleiboeker H, Saddler CM, Smith JA, Rice JP, Mandelbrot DA, Odorico JS, Jorgenson MR. The UW Experience: Feasibility of De Novo Letermovir for Primary Prophylaxis After Abdominal Solid Organ Transplant. Ann Pharmacother. 2025:10600280241307383.
15. Di Molfetta G, Pola I, Tan K, Isaacson R, Blennow K, Ashton NJ, Benedet AL, Zetterberg H. Inflammation biomarkers and Alzheimer's disease: A pilot study using NULISAseq. Alzheimers Dement (Amst). 2025;17(1):e70079.
16. Duff EP, Zetterberg H, Heslegrave A, Dehghan A, Elliott P, Allen N, Runz H, Laban R, Veleva E, Whelan CD, Sun BB, Matthews PM. Plasma proteomic evidence for increased β-amyloid pathology after SARS-CoV-2 infection. Nat Med. 2025.
17. Edmunds KJ, Pandos AA, Hoang I, Mamlouk GM, Motovylyak A, Lose SR, Asthana S, Stremlau M, Johnson SC, van Praag H, Okonkwo OC. BDNF expression mediates verbal learning and memory in women in a cohort enriched with risk for Alzheimer's disease. Alzheimers Dement (Amst). 2025;17(1):e70062.
18. Esnault S, Dill-McFarland KA, Altman MC, Rosenkranz MA, Jarjour NN, Busse WW. Identification of bronchial epithelial genes associated with type 2 eosinophilic inflammation in asthma. J Allergy Clin Immunol. 2025.
19. Fernández Arias J, Brum WS, Salvadó G, Therriault J, Servaes S, Wang YT, Aumont E, Rahmouni N, Macedo A, Quispialaya K, Hosseini SA, Kunach P, Jia WL, Chan T, Trudel L, Hall B, Zheng Y, Mohapatra S, Mathotaarachchi SS, Vitali P, Tissot C, Bezgin G, Iturria-Medina Y, Ashton NJ, Benedet AL, Karikari TK, Triana-Baltzer G, Klostranec J, Kolb HC, Zimmer ER, Janelidze S, Mattson-Carlgren N, Stomrud E, Palmqvist S, Zetterberg H, Blennow K, Pascoal T, Montembeault M, Hansson O, Rosa-Neto P. Plasma phosphorylated tau217 strongly associates with memory deficits in the Alzheimer's disease spectrum. Brain. 2025.
20. Gadila SKG, Caskey JR, Breitschwerdt EB, Maggi RG, Embers ME. Comparison of transcriptomic profiles between intracellular and extracellular Bartonella henselae. Commun Biol. 2025;8(1):143.
21. Gallifant J, Afshar M, Ameen S, Aphinyanaphongs Y, Chen S, Cacciamani G, Demner-Fushman D, Dligach D, Daneshjou R, Fernandes C, Hansen LH, Landman A, Lehmann L, McCoy LG, Miller T, Moreno A, Munch N, Restrepo D, Savova G, Umeton R, Gichoya JW, Collins GS, Moons KGM, Celi LA, Bitterman DS. The TRIPOD-LLM reporting guideline for studies using large language models. Nat Med. 2025;31(1):60-69.
22. Gao Y, Myers S, Chen S, Dligach D, Miller T, Bitterman DS, Chen G, Mayampurath A, Churpek MM, Afshar M. Uncertainty estimation in diagnosis generation from large language models: next-word probability is not pre-test probability. JAMIA Open. 2025;8(1):ooae154.
23. Ghose R, Forati AM, Mohebbi F, Mantsch JR. Spatial-Structural Mechanisms of Racialized Disparities in Overdose Mortality: A Spatiotemporal Analysis. J Racial Ethn Health Disparities. 2025.
24. Gleerup HS, Simonsen AH, Grötschel L, Gramkow MH, Høgh P, Blennow K, Zetterberg H, Ashton N, Hasselbalch SG. Plasma biomarkers of amyloid, tau, astrogliosis, and axonal injury in a mixed memory clinic cohort. Alzheimers Dement (Amst). 2025;17(1):e70073.
25. Goldman MP, Patel DM, Chang KZ, Davis RP, Edwards MS, Hurie JB, Sutsrim A, Velazquez-Ramirez G, Williams TK, Grandas OH, Freeman MB, McNally MM, Stevens SL, Bennett KM, Woo K, Carsten CG, Androes MP, Blas JV, Jones B, Patton RM, Parr R, Gandhi SS, York JW, Young CJ, Rabbani MU, Gardezi AI, Abdelnour LM, Lee T, Abusalah WM, Zayas CF, Hicks CW, Geetha D, Brown WM, Chen H, Allon M, Murea M. Challenges and potential solutions to enrollment in a clinical trial of arteriovenous fistula vs arteriovenous graft vascular access strategy. JVS Vasc Insights. 2024;2.
26. Gooding DC, Van Hulle CA, Zuelsdorff M, Lewis JP, Carter FP, Salazar H, Bouges S, James TT, Gee A, Gleason CE. Perceptions about preclinical Alzheimer's disease biomarker collection procedure influences willingness to participate: Findings from an ethnoracially diverse study. J Alzheimers Dis. 2025:13872877241307255.
27. Göteson A, Holmén-Larsson J, Celik H, Pelanis A, Sellgren CM, Sparding T, Pålsson E, Zetterberg H, Blennow K, Jonsson L, Gobom J, Landén M. MAPPING THE CEREBROSPINAL FLUID PROTEOME IN BIPOLAR DISORDER. Biol Psychiatry. 2025.
28. Gregory AL, Bussan HE, Topf MA, Hryckowian AJ. Impacts of perR on oxygen sensitivity, gene expression, and murine infection in Clostridioides difficile 630∆erm. J Bacteriol. 2025:e0046824.
29. Grilley BJ, Hume A, Galipeau J. Sickle cell disease gene therapy drug expenses and reimbursement: a litmus test for commercial pricing strategy and patient access for curative therapies. Cytotherapy. 2025.
30. Gschwend MH, Marchese AM, Poelaert D, Warren B, Rousculp MD, Caldera F. Efficacy, immunogenicity, and safety of the Novavax COVID-19 vaccine in immunocompromised patients: A targeted literature review. Vaccine. 2025;49:126777.
31. Hamdan MH, Brignole M, Michelet P, Deharo JC, Guieu R. The Effect of Capsaicin-Phenylephrine-Caffeine Formulation on Tilt Induced Syncope in Patients with a History of Vasovagal Syncope or Near Syncope. Heart Rhythm. 2025.
32. Harr TJ, Gupta N, Rahar B, Stott K, Medina-Guevara Y, Gari MK, Oler AT, McDermott IS, Lee HJ, Rasoulianboroujeni M, Weichmann AM, Forati A, Holbert K, Langel TS, Coulter KW, Burkel BM, Tomasini-Johansson BR, Ponik SM, Engle JW, Hernandez R, Kwon GS, Sandbo N, Bernau K. The fibronectin-targeting PEG-FUD imaging probe shows enhanced uptake during fibrogenesis in experimental lung fibrosis. Respir Res. 2025;26(1):34.
33. Hegde Y, Hayney MS, Caldera F. Live Typhoid and Yellow Fever Vaccines Administered to a Patient With Ulcerative Colitis on Vedolizumab. ACG Case Rep J. 2024;11(10):e01507.
34. Jang DG, Kind AJ, Patterson A, Pedde M, Powell WR, Feldman EL, Goutman SA. Impact of the Adverse Social Exposome on Survival in Individuals With Amyotrophic Lateral Sclerosis. Neurology. 2025;104(4):e213362.
35. Jauregi-Zinkunegi A, Betthauser T, Carlsson CM, Bendlin BB, Okonkwo O, Chin NA, Asthana S, Langhough RE, Johnson SC, Mueller KD, Bruno D. Delayed primacy recall in AVLT is associated with medial temporal tau PET burden in cognitively unimpaired adults. Cortex. 2025;184:47-57.
36. Jauregi-Zinkunegi A, Gleason CE, Bendlin B, Okonkwo O, Hermann BP, Blennow K, Zetterberg H, Hogervorst E, Johnson SC, Langhough R, Mueller KD, Bruno D. Menopausal hormone therapy is associated with worse levels of Alzheimer's disease biomarkers in APOE ε4-carrying women: An observational study. Alzheimers Dement. 2025.
37. Jegatheesan P, Belogolovsky E, Nudelman M, Narasimhan SR, Huang A, Govindaswami B, Song D. Longer Duration of Cord Clamping Improves Nicu Survival Without Major Morbidities in Very Preterm Infants. Children (Basel). 2024;11(12).
38. Jenkins WD, Beach LB, Schneider J, Friedman SR, Pho MT, Walters S, Ezell J, Young AM, Hennessy C, Miller W, Go VF, Sun C, Seal DW, Westergaard RP, Crane HM, Fredericksen RJ, Ruderman SA, Fletcher S, Ma J, Delaney JA, Plaisance K, Feinberg J, Smith GS, Korthuis PT, Stopka TJ, Friedmann PD, Zule W, Winer M. Sexual identity, sexual behavior, and drug use behaviors among people who use drugs in the rural U.S. J Subst Use Addict Treat. 2025:209629.
39. Johnsson M, Eriksson K, Rosenstein I, Novakova L, Malmeström C, Lycke J, Sandgren S, Zetterberg H, Blennow K, Johansson K, Axelsson M. The value of CSF diagnostic and prognostic biomarkers in NMOSD and MOGAD in real-life use. Mult Scler Relat Disord. 2025;94:106302.
40. Jutten RJ, Ho EH, Karpouzian-Rogers T, van Hulle C, Carlsson C, Dodge HH, Nowinski CJ, Gershon R, Weintraub S, Rentz DM. Computerized cognitive testing to capture cognitive decline in Alzheimer's disease: Longitudinal findings from the ARMADA study. Alzheimers Dement (Amst). 2025;17(1):e70046.
41. Kamaraju S, Fowler AM, Tarima S, Chaudhary LN, Burkard ME, Giever T, Cheng YC, Parkes A, Lange CA, Pipp-Dahm M, Hegeman R, Siddiqui N, Stella A, Rajguru S, Twaroski K, Zurbriggen L, Jorns JM, Rui H, Keigley QJ, Perlman SB, Salem K, Bradshaw TJ, Sahmoud T, Wisinski K. A Phase II Trial of Onapristone and Fulvestrant for Patients With ER+ and HER2- Metastatic Breast Cancer. Clin Breast Cancer. 2024.
42. Kindler HL, Ismaila N, Bazhenova L, Chu Q, Churpek JE, Dagogo-Jack I, Bryan DS, Drazer MW, Forde P, Husain AN, Sauter JL, Rusch V, Bradbury PA, Cho BCJ, de Perrot M, Ghafoor A, Graham DL, Khorshid O, Lebensohn A, White J, Hassan R. Treatment of Pleural Mesothelioma: ASCO Guideline Update. J Clin Oncol. 2025:Jco2402425.
43. Li D, An B, Men L, Glittenberg M, Lutsey PL, Mielke MM, Yu F, Hoogeveen RC, Gottesman R, Zhang L, Meyer M, Sullivan K, Zantek N, Alonso A, Walker KA. The association of high-density lipoprotein cargo proteins with brain volume in older adults in the Atherosclerosis Risk in Communities (ARIC). J Alzheimers Dis. 2025:13872877241305806.
44. Linard M, Garrigue I, Vellas B, Coley N, Zetterberg H, Blennow K, Ashton NJ, Payoux P, Salabert AS, Dartigues JF, Mazere J, Andrieu S, Helmer C. Association between herpes simplex virus infection and Alzheimer's disease biomarkers: analysis within the MAPT trial. Sci Rep. 2025;15(1):2362.
45. Long MT, Krause BM, de Jong A, Dollerschell JT, Brewer JM, Casey JD, Gaillard JP, Gandotra S, Ghamande SA, Gibbs KW, Ginde AA, Hughes CG, Janz DR, Khan A, Latimer A, Mitchell S, Page DB, Russell DW, Self WH, Semler MW, Stempek S, Trent S, Vonderhaar DJ, West JR, Halliday SJ. Diabetes Mellitus Is Not a Risk Factor for Difficult Intubation Among Critically Ill Adults: A Secondary Analysis of Multicenter Trials. Crit Care Med. 2025;53(1):e65-e73.
46. Ly MT, Altaras C, Tripodis Y, Adler CH, Balcer LJ, Bernick C, Zetterberg H, Blennow K, Peskind ER, Banks SJ, Barr WB, Wethe JV, Lenio S, Bondi MW, Delano-Wood LM, Cantu RC, Coleman MJ, Dodick DW, Mez J, Daneshvar DH, Palmisano JN, Martin B, Lin AP, Koerte IK, Bouix S, Cummings JL, Reiman EM, Shenton ME, Stern RA, Alosco ML. Single- versus two-test criteria for cognitive impairment: associations with CSF and imaging markers in former American football players. Clin Neuropsychol. 2025:1-25.
47. Ma Y, Mora Pinzon MC, Buckingham WR, Bersch AJ, Powell WR, LeCaire TJ, Ennis GE, Deming Y, Jonaitis EM, Chin NA, Clark LR, Edwards DF, Walaszek A, Okonkwo OC, Zuelsdorff M, Chappell RJ, Johnson SC, Asthana S, Gleason CE, Kind AJ, Bendlin BB, Carlsson CM. Comparison of sample characteristics of Wisconsin Alzheimer's Disease Research Center participants with the Wisconsin state population-An evaluation of the recruitment effort. Alzheimers Dement (N Y). 2025;11(1):e70036.
48. Matthews MC, Patel MA, Rodenbach RA, Commers W, Campbell TC. Utilizing Simulated Telemedicine Encounters to Conduct Nationwide Studies of Physician Communication Practices. J Palliat Med. 2025.
49. McKeever A, Swann P, Malpetti M, Donaghy PC, Thomas A, Mak E, Carter SF, Tan JHK, Hong YT, Fryer TD, Heslegrave A, Zetterberg H, Su L, Chouliaras L, Rowe JB, O'Brien JT. Polygenic risk discriminates Lewy body dementia from Alzheimer's disease. Alzheimers Dement. 2025:e14381.
50. McKinley L, Hicks N, Keating J, Fritz C, Penavs I, Safdar N. Staffing Paradigm for Infection Prevention and Control in the Era of Antimicrobial Resistance: the Veterans Health Administration Experience. Am J Infect Control. 2025.
51. Narayanan P, Lucey MR. Larsucosterol Moves Forward as a Treatment Contender for Alcohol-Associated Hepatitis. NEJM Evid. 2025;4(2):EVIDe2400434.
52. Neth BJ, Huynh K, Giles C, Wang T, Mellett NA, Duong T, Blach C, Schimmel L, Register TC, Blennow K, Zetterberg H, Batra R, Schweickart A, Dilmore AH, Martino C, Arnold M, Krumsiek J, Han X, Dorrestein PC, Knight R, Meikle PJ, Craft S, Kaddurah-Daouk R. Consuming a modified Mediterranean ketogenic diet reverses the peripheral lipid signature of Alzheimer's disease in humans. Commun Med (Lond). 2025;5(1):11.
53. Ng B, Zetterberg H. Know your brain aging to know your resilience in neurodegenerative diseases. Brain Commun. 2025;7(1):fcae467.
54. Oomens JE, van Gils V, Vos SJB, Freeze WM, Maserejian NN, Curiale G, Gillis C, Boada M, van der Flier WM, Hort J, Johnson SC, Lleó A, Ramakers IH, Rodrigue KM, Sánchez-Juan P, Sarazin M, Scarmeas N, Zetterberg H, Alcolea D, Barkhof F, Blennow K, Bottlaender M, den Braber A, Cerman J, Drake-Perez M, Fortea J, Handels R, Ingala S, Jiménez-Bonilla JF, Karavasilis S, Lagarde J, Legdeur N, Lorenzini L, Marquié M, Moonen JEF, Olivieri P, Orellana A, Ossenkoppele R, Rivera-Rivera LA, Rodríguez-Rodriguez E, Ruiz Laza A, Teunissen CE, Tijms BM, Velonakis G, Verhey FRJ, Visser PJ, Jansen WJ. Cerebral Microbleeds and Amyloid Pathology Estimates From the Amyloid Biomarker Study. JAMA Netw Open. 2025;8(1):e2455571.
55. Pan AY, Khorsandi PJ, Farnan JM, German MN, Barman PM, Berschback MA, Kriss M, McMillan R, Mousa O, Peng FB, Randhawa T, Scales K, Mikolajczyk AE. Lessons Learned From the Liver About the Undergraduate to Graduate Medical Education Transition. In: Am J Med Open. Vol 13. United States: © 2024 The Author(s). 2025:100079.
56. Polunosika E, Simren J, Akmene A, Klimovskis N, Blennow K, Pastare D, Zetterberg H, Erts R, Karelis G. Functional and Cognitive Impairment in Patients with Relapsing-Remitting Multiple Sclerosis: Cognitive Tests and Plasma Neurofilament Light Chain Levels. Medicina (Kaunas). 2025;61(1).
57. Pretkalnina D, Kenina E, Gailite L, Rots D, Blennow K, Zetterberg H, Kenina V. Evaluating plasma biomarkers NfL, GFAP, GDF15, and FGF21 as indicators of disease severity in Charcot-Marie Tooth patients. Front Neurol. 2024;15:1490024.
58. Raj SA, Zhou AL, Fedorova E, Yuan Z, Mandelbrot DA, Astor BC, Parajuli S. Low 25-Hydroxyvitamin D Post-Kidney Transplant Is Associated with Increased Risk of BK Polyomavirus-Associated Nephropathy. Microorganisms. 2024;12(12).
59. Rydén L, Seidu NM, Wetterberg H, Najar J, Waern M, Kern S, Blennow K, Zetterberg H, Skoog I, Zettergren A. Polygenic risk scores for atrial fibrillation and heart failure and the risk of stroke and dementia. Brain Commun. 2025;7(1):fcae477.
60. Sannaa W, Almasry M, Peedikayil M, Grimshaw AA, Attamimi M, AlMutairdi A, Al-Bawardy B. Effectiveness and safety of oral vancomycin for the treatment of inflammatory bowel disease associated with primary sclerosing cholangitis: a systematic review and pooled analysis. Therap Adv Gastroenterol. 2025;18:17562848241312766.
61. Scahill RI, Farag M, Murphy MJ, Hobbs NZ, Leocadi M, Langley C, Knights H, Ciosi M, Fayer K, Nakajima M, Thackeray O, Gobom J, Rönnholm J, Weiner S, Hassan YR, Ponraj NKP, Estevez-Fraga C, Parker CS, Malone IB, Hyare H, Long JD, Heslegrave A, Sampaio C, Zhang H, Robbins TW, Zetterberg H, Wild EJ, Rees G, Rowe JB, Sahakian BJ, Monckton DG, Langbehn DR, Tabrizi SJ. Somatic CAG repeat expansion in blood associates with biomarkers of neurodegeneration in Huntington's disease decades before clinical motor diagnosis. Nat Med. 2025.
62. Scherzer ZA, Astor BC, Lesnik D, Maursetter L. CKD Management in the Age of Telenephrology: An Observational Analysis of a Hybrid Telenephrology System within a Veteran's Affairs Medical Center. Kidney360. 2024.
63. Schöll M, Vrillon A, Ikeuchi T, Quevenco FC, Iaccarino L, Vasileva-Metodiev SZ, Burnham SC, Hendrix J, Epelbaum S, Zetterberg H, Palmqvist S. Cutting through the noise: A narrative review of Alzheimer's disease plasma biomarkers for routine clinical use. J Prev Alzheimers Dis. 2025:100056.
64. Schumacher JR, Tucholka JL, Breuer CR, McKinney GH, Maxcy C, Stankowski-Drengler TJ, Marka NA, Hanlon BM, Kwekkeboom KL, Tevaarwerk AJ, Haine JE, Neuman HB. Ongoing Symptoms and Concerns Experienced by Low-Risk Breast Cancer Survivors Following Active Treatment. Ann Surg Oncol. 2025.
65. Slotwiner DJ, Serwer GA, Allred JD, Bhakta D, Clark R, Durand J, Ferrara MG, Hale J, Irving C, Iverson A, Jin M, Johansen JB, Kalscheur M, Krisjnen D, Lerman R, Lippman N, Mendenhall GS, Michael R, Nichols S, Parkash R, Ray N, Reister C, Skipitaris NT, Solomon H, Steiner PR, Tietz M, Wan EY, Wadhwa M. 2024 HRS perspective on advancing workflows for CIED remote monitoring. Heart Rhythm O2. 2024;5(12):845-853.
66. Smith JA. Invisible Me. Jama. 2025.
67. Stalter L, Venkatesh M, Jacobs J, Stype A, Langa KM, Byers AL, Wyman MF. Data Resource Profile: The Veterans Affairs-Health and Retirement Study Aging Veteran Cohort. J Am Geriatr Soc. 2025.
68. Sweet N, Huang H, Bartels CM. Mind Matters in Rheumatoid Arthritis: The Rising Burden of Anxiety and Depression. J Rheumatol. 2025.
69. Ukachukwu CU, Jimenez-Vazquez EN, Salwi S, Goodrich M, Sanchez-Conde FG, Orland KM, Jain A, Eckhardt LL, Kamp TJ, Jones DK. A PAS-targeting hERG1 activator reduces arrhythmic events in Jervell and Lange-Nielsen syndrome patient-derived hiPSC-CMs. JCI Insight. 2025.
70. Wang YT, Ashton NJ, Therriault J, Benedet AL, Macedo AC, Pola I, Aumont E, Di Molfetta G, Fernandez-Arias J, Tan K, Rahmouni N, Servaes SJG, Isaacson R, Chan T, Hosseini SA, Tissot C, Mathotaarachchi S, Stevenson J, Lussier FZ, Pascoal TA, Gauthier S, Blennow K, Zetterberg H, Rosa-Neto P. Identify biological Alzheimer's disease using a novel nucleic acid-linked protein immunoassay. Brain Commun. 2025;7(1):fcaf004.
71. Wiels WA, Oomens JE, Engelborghs S, Baeken C, von Arnim CAF, Boada M, Didic M, Dubois B, Fladby T, van der Flier WM, Frisoni GB, Fröhlich L, Gill KD, Grimmer T, Hildebrandt H, Hort J, Itoh Y, Iwatsubo T, Klimkowicz-Mrowiec A, Lee DY, Lleó A, Martinez-Lage P, de Mendonça A, Meyer PT, Kapaki EN, Parchi P, Pardini M, Parnetti L, Popp J, Rami L, Reiman EM, Rinne JO, Rodrigue KM, Sánchez-Juan P, Santana I, Sarazin M, Scarmeas N, Skoog I, Snyder PJ, Sperling RA, Villeneuve S, Wallin A, Wiltfang J, Zetterberg H, Ossenkoppele R, Verhey FRJ, Vos SJB, Visser PJ, Jansen WJ, Alcolea D, Altomare D, Baiardi S, Baldeiras I, Bateman RJ, Blennow K, Bottlaender M, den Braber A, van Buchem MA, Byun MS, Cerman J, Chen K, Chipi E, Day GS, Drzezga A, Eckerström M, Ekblad LL, Epelbaum S, Förster S, Fortea J, Freund-Levi Y, Frings L, Guedj E, Hausner L, Hellwig S, Huey ED, Jiménez-Bonilla JF, Johnson KA, Juaristi AI, Kandimalla R, Paraskevas G, Kern S, Kirsebom BS, Kornhuber J, Lagarde J, Landau SM, Legdeur N, Llibre Guerra JJ, Maserejian NN, Marquié M, Minatani S, Morbelli SD, Mroczko B, Ntanasi E, de Oliveira CR, Olivieri P, Orellana A, Perrin RJ, Peters O, Prabhakar S, Ramakers IH, Rodríguez-Rodriguez E, Ruiz A, Rüther E, Selnes P, Silva D, Soininen H, Spiru L, Takeda A, Teichmann M, Tijms BM, Teunissen CE, Thompson LI, Vogelgsangs J, Vöglein J, Waldemar G, Wallin Å K, Yannakoulia M, Yi D, Zettergren A. Depressive Symptoms and Amyloid Pathology. JAMA Psychiatry. 2025.
72. Witbracht M, Xu Y, Morgan OB, Salazar CR, Hoang D, Kind A, Gillen DL, Grill JD. Research Attitudes Questionnaire scores and retention in a recruitment registry. J Alzheimers Dis. 2025:13872877241302422.
73. Wu CY, Kupferschmid AC, Chen L, McManus AJ, Kivisäkk P, Galler JA, Schwab NA, DesRuisseaux LA, Williams VJ, Gerber J, Riley M, Young C, Guzmán-Vélez E, Dodge HH, Tanzi RE, Singer CM, Arnold SE. Cognitive and Alzheimer's disease biomarker effects of oral nicotinamide riboside (NR) supplementation in older adults with subjective cognitive decline and mild cognitive impairment. Alzheimers Dement (N Y). 2025;11(1):e70023.
74. Young KS, Hancock GR, Fink EC, Zigrossi A, Flowers B, Cooper DA, Nguyen VT, Martinez MC, Mon KS, Bosland M, Zak DR, Runde AP, Sharifi MN, Kastrati I, Minh DDL, Kregel S, Fanning SW. Targeting unique ligand binding domain structural features downregulates DKK1 in Y537S ESR1 mutant breast cancer cells. Breast Cancer Res. 2025;27(1):10.